8.8 Conditions Prohibiting Dispensing, Quarantine, Returned Drugs & Charitable Reuse
Key Takeaways
Oregon pharmacists must document, quarantine and physically separate recalled, outdated, damaged, misbranded, adulterated, counterfeit or suspect drugs until they are destroyed or returned.
An Oregon pharmacy may not dispense a drug that will expire before the course of therapy ends, or one obtained from a source not registered in Oregon.
Oregon pharmacists, technicians and interns may never accept returns of controlled substances; patients use take-back receptacles or mail-back instead.
In Oregon, returned drugs may be redispensed only if unopened, tamper-evident and kept in a long-term care or supervised-living setting under consultant-pharmacist oversight.
Oregon's Charitable Prescription Drug Program redistributes sealed donated drugs with lot and expiration dates to needy patients, but only if they expire at least nine months after donation.
Why this matters
Area 3.7 covers "drug product conditions prohibiting dispensing," and Area 2.4 covers "returning or reusing drugs." The two are linked. A product that has left pharmacy control, or is adulterated, misbranded, expired, recalled, suspect or improperly stored, generally cannot be dispensed. Oregon has explicit rules on quarantine, returns and limited redispensing.
Conditions that prohibit dispensing
| Condition | Legal basis | What the pharmacist does |
|---|---|---|
| Adulterated (contaminated, not made under cGMP, below USP strength or purity, stored improperly) | FDCA 501 (21 U.S.C. 351); ORS 689.527(3)–(4) | Quarantine; do not dispense |
| Misbranded (false or misleading label, missing required information or warnings) | FDCA 502 (21 U.S.C. 352); ORS 689.505 | Quarantine; do not dispense |
| Outdated, or will expire before the course of therapy ends | OAR 855-041-1130 (see note) | Do not dispense |
| Recalled | FDA recall classes I–III | Quarantine and follow the recall notice |
| Counterfeit, suspect or illegitimate (DSCSA) | 21 U.S.C. 360eee-1 | Quarantine, investigate, notify FDA and trading partners within 24 hours if illegitimate (section 11.2) |
| Temperature excursion not cleared as safe | OAR 855-041-1036(2)(b) | Quarantine until the pharmacist decides, using a documented source, whether it is safe or must be destroyed |
| Acquired from an unregistered source | OAR 855-115-0125(3) | Do not dispense; drugs must come from an Oregon-registered outlet |
| Damaged after a fire, flood or power loss | OAR 855-007-0120; ORS 689.135(14) | Treat as adulterated unless shown to be safe; the Board may embargo |
Quarantine rule: drugs and devices that are recalled, outdated, damaged, deteriorated, misbranded, adulterated, counterfeit, suspect or illegitimate, or otherwise unfit, must be documented, quarantined and physically separated until destroyed or returned to the supplier (OAR 855-115-0125(5); OAR 855-041-1036(1)(d); OAR 855-041-1025). The Board's self-inspection form asks where the quarantine area is and how quarantined controlled substances are kept secure.
FDA recall classes
- Class I: a reasonable probability of serious adverse health consequences or death.
- Class II: may cause temporary or medically reversible effects, or the chance of serious harm is remote.
- Class III: unlikely to cause adverse health consequences.
Pharmacies follow the recall's depth (wholesale, retail or consumer), quarantine the stock and contact patients when the recall reaches the consumer level.
Returned drugs (OAR 855-041-1045)
- Controlled substances: pharmacists, technicians and interns may not accept the return of controlled substances. A patient who wants to dispose of controlled substances uses an authorized collection receptacle (take-back), a mail-back package or a take-back event. Staff never handle the returned drugs (section 11.4).
- Returns for destruction only: pharmacy personnel may accept a drug or device that left the pharmacy if it was:
- Dispensed in error.
- Defective, adulterated or misbranded.
- Dispensed beyond its expiration date.
- Undeliverable to the patient.
- Subject to a recall. A pharmacist may also accept a return when professional judgment says harm could result otherwise.
- Return and redispensing: a previously dispensed drug may be returned to stock and redispensed only if:
- It is in unopened, tamper-evident packaging.
- It was kept under proper control in a long-term care or supervised-living setting with consultant pharmacist oversight.
- It was stored per the manufacturer and is not adulterated or misbranded.
Will-call returns to stock, meaning prescriptions never picked up, never left the pharmacy, so they can return to inventory. A technician or intern who does this needs pharmacist verification documented, and the claim and any PDMP report are corrected as needed. A returned-to-stock prescription is removed from any auto-refill program (OAR 855-041-1120(6)).
Reuse through the Charitable Prescription Drug Program (ORS 689.770–689.780)
Oregon's Charitable Prescription Drug Program lets Board-registered, Board-approved outlets accept donated prescription drugs and distribute them to needy or uninsured people. Donations must be in original, sealed, tamper-evident packaging showing the lot number and expiration date. Sealed single-unit-dose packages from opened multi-dose cartons, and drugs repackaged by another charitable program, are also accepted. The program may not distribute drugs that:
- Expire less than nine months after donation.
- Are adulterated or misbranded.
- Belong to a controlled-substance category the Board excludes by rule.
Participants who act in good faith are immune from liability (ORS 689.772, 689.780).
Warning
A patient's unopened, sealed box of insulin pens returned from home cannot be redispensed in an Oregon community pharmacy. The redispensing exception covers only drugs kept in long-term care or supervised-living settings under consultant-pharmacist control. Proper handling outside the pharmacy cannot be verified.
Exam scenario
A patient returns two items:
- Unopened oxycodone tablets ("I don't need them"). The pharmacy may not accept them. Staff direct the patient to the pharmacy's DEA-authorized collection receptacle, which is in view of but not behind the counter, or to another disposal option.
- A sealed albuterol inhaler dispensed in error last week (wrong patient). The pharmacist may accept it for destruction, because it was dispensed in error, but may not return it to stock for another patient.
The pharmacist documents both events.
A patient brings back an unopened bottle of hydrocodone/acetaminophen dispensed last week and asks the pharmacist to take it back. What may the pharmacist do under OAR 855-041-1045?
Accept it and return it to stock because the seal is intact
Accept it for destruction and log it on a DEA Form 41
Accept it if the patient signs a return form
Decline to accept it and direct the patient to an authorized collection receptacle or other DEA-authorized disposal option
Which previously dispensed product may an Oregon pharmacy lawfully redispense?
Unopened, tamper-evident unit-dose tablets returned from a long-term care facility where they were kept under consultant-pharmacist oversight and stored properly
A sealed insulin pen box returned from a patient's home refrigerator
A partially used inhaler returned because of a taste complaint
Any sealed product the patient says was stored correctly
Under ORS 689.772, which donated drug may the Charitable Prescription Drug Program distribute?
An opened bottle with a missing lot number
A sealed carton expiring five months after donation
A sealed, tamper-evident package showing its lot number and expiring 14 months after donation
A misbranded product repackaged by a patient
Sections you finish are checked off in the contents.